seed
Stage
1
Investors
About
Ternary Therapeutics develops AI-driven and physics-based computational tools to design small-molecule molecular glue therapeutics that promote protein-protein interactions for drug discovery.
Explore Ternary Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.